000			02030 a2200613 4500
005			20250515031538.0
264		0	_c20070329
008			200703s 0 0 eng d
022			_a1462-8902
024	7		_a10.1111/j.1463-1326.2006.00602.x _2doi
040			_aNLM _beng _cNLM
100	1		_aBlonde, L
245	0	0	_aInterim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes. _h[electronic resource]
260			_bDiabetes, obesity & metabolism _cJul 2006
300			_a436-47 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aBlood Glucose _xmetabolism
650	0	4	_aBlood Pressure
650	0	4	_aBody Weight _xdrug effects
650	0	4	_aCardiovascular Diseases _xetiology
650	0	4	_aDiabetes Mellitus, Type 2 _xblood
650	0	4	_aDiabetic Angiopathies _xblood
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Therapy, Combination
650	0	4	_aExenatide
650	0	4	_aFemale
650	0	4	_aGlycated Hemoglobin _xmetabolism
650	0	4	_aHumans
650	0	4	_aHypoglycemic Agents _xadverse effects
650	0	4	_aLipids _xblood
650	0	4	_aMale
650	0	4	_aMetformin _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aOverweight
650	0	4	_aPeptides _xadverse effects
650	0	4	_aRisk Factors
650	0	4	_aSulfonylurea Compounds _xtherapeutic use
650	0	4	_aVenoms _xadverse effects
650	0	4	_aWeight Loss _xdrug effects
700	1		_aKlein, E J
700	1		_aHan, J
700	1		_aZhang, B
700	1		_aMac, S M
700	1		_aPoon, T H
700	1		_aTaylor, K L
700	1		_aTrautmann, M E
700	1		_aKim, D D
700	1		_aKendall, D M
773	0		_tDiabetes, obesity & metabolism _gvol. 8 _gno. 4 _gp. 436-47
856	4	0	_uhttps://doi.org/10.1111/j.1463-1326.2006.00602.x _zAvailable from publisher's website
999			_c16371585 _d16371585